Black Friday Sale! Save huge on InvestingProGet up to 60% off

UPDATE 2-Healthcare drags FTSE 100 down; Vodafone jumps

Published 02/03/2021, 05:17 PM
Updated 02/04/2021, 01:20 AM
© Reuters.
UK100
-
VOD
-
GSK
-
FTMC
-
FTNMX452010
-
FTNMX303010
-
GLEN
-
5CV
-

(For a Reuters live blog on U.S., UK and European stock
markets, click LIVE/ or type LIVE/ in a news window)
* GlaxoSmithKline slumps on COVID-19 vaccine development
* Vodafone gains after earnings beat estimates
* Glencore rises after maintaining 2021 output targets
* FTSE 100 down 0.1%, FTSE 250 adds 0.3%

(Updates to close)
By Shashank Nayar, Amal S and Shivani Kumaresan
Feb 3 (Reuters) - The FTSE 100 slipped on Wednesday, as
falls in healthcare stocks offset gains elsewhere driven by
investors' hopes that mass vaccinations would accelerate an
economic revival, while Vodafone jumped after its earnings beat
estimates.
GlaxoSmithKline Plc GSK.L lost 6.3% and was the biggest
drag on the index, after warning of a bigger than expected fall
in 2021 earnings as the COVID-19 pandemic continues to disrupt
other areas of healthcare. "GSK's expected new dividend policy will mean lower payouts,
and thus the stock, a noted income stream for investors, has
taken a knock, with fears that AstraZeneca might have to follow
suit, leading to a small decline for that company's shares too,"
said Chris Beauchamp, chief market analyst at IG.
The blue-chip FTSE 100 index .FTSE slid 0.1%, with
AstraZeneca Plc AZN.L , Smith & Nephew plc SN.L and Hikma
Pharmaceuticals HIK.L also weighing on the index, while the
mid-cap index .FTMC added 0.3%.
The export-oriented and commodity stocks-heavy FTSE 100 has
rebounded from early-2021 losses to trade 1.3% higher for the
year, as vaccinations pick up pace, corporate earnings improve
and commodity prices increase.
A survey indicated that Britain's third national coronavirus
lockdown has put the economy on course for a sharp contraction
in early 2021, but services companies - buoyed by progress on
vaccinations - are confident about recovery. Britain's health minister on Wednesday defended his decision
to give a shot developed by Oxford University and AstraZeneca to
all age groups including over-65s, saying this was supported by
scientific evidence. Vodafone VOD.L , the world's second-largest mobile
operator, rose 5.9% and was the top boost to the FTSE 100 after
saying its organic service revenue returned to growth in its
third quarter, beating analysts' expectations. Glencore GLEN.L , which mines coal, nickel, silver, zinc
and copper, added 0.9% after affirming all of its production
targets for 2021.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.